Published online Feb 15, 2022. doi: 10.4251/wjgo.v14.i2.396
Peer-review started: September 7, 2021
First decision: November 8, 2021
Revised: November 8, 2021
Accepted: January 5, 2022
Article in press: January 5, 2022
Published online: February 15, 2022
Processing time: 156 Days and 5.6 Hours
The most common histological type of gastric cancer (GC) is gastric adenocarcinoma arising from the gastric epithelium. Less common variants include mesenchymal, lymphoproliferative and neuroendocrine neoplasms. The Lauren scheme classifies GC into intestinal type, diffuse type and mixed type. The WHO classification includes papillary, tubular, mucinous, poorly cohesive and mixed GC. Chronic atrophic gastritis (CAG) and intestinal metaplasia are recommended as common precancerous conditions. No definite precancerous condition of diffuse/poorly/undifferentiated type is recommended. Chronic superficial inflammation and hyperplasia of foveolar cells may be the focus. Presently, the management of early GC and precancerous conditions mainly relies on endoscopy including diagnosis, treatment and surveillance. Management of precancerous conditions promotes the early detection and treatment of early GC, and even prevent the occurrence of GC. In the review, precancerous conditions including CAG, metaplasia, foveolar hyperplasia and gastric hyperplastic polyps derived from the gastric epithelium have been concluded, based on the overview of gastric epithelial histological organization and its renewal.
Core Tip: We provided a detailed overview of gastric epithelial organization and its renewal and reviewed precancerous conditions including chronic atrophic gastritis, spasmolytic polypeptide-expressing metaplasia, intestinal metaplasia, foveolar hyperplasia and gastric hyperplastic polyps derived from gastric epithelium based on histological perspective, covering their epidemiology, clinical management and advances, histological structure, causes and potential origin and reversibility. The origins, processes and reversibility are the main controversial topics. More clinical and basic research on molecular alterations of these gastric lesions may shed light on the controversies.